Prognostic Value of Some Biochemical Markers in Breast Cancer

Sohag University90 enrolled

Overview

breast cancer is the most common type of cancer in women and first cause of cancer death among them. in Egypt it constitutes 33% of female cancer cases and more than22000 new cases diagnosed each year. there are many prognostic factors for breast cancer as Tumer size, axillary lymph node status, hormonal receptor status, and tumer markers as Ca15-3 and interferon gamma.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Breast Cancer Female

Interventions

serum sample for ELIZADIAGNOSTIC_TEST

ELIZA for Ca15-3 and interferon gamma

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * female patients aged more than or equal 18 year diagnosed with breast cancer * metastatic and non-metastatic cancer premenopausal and postmenopausal female positive and negative hormonal receptors and HER2 receptor taking any systemic treatment taking radiotherapy or not Exclusion Criteria: * female patients less than 18 years patients having comorbid disease. patients with double malignancy

Locations (1)

Sohag University Hospital

Sohag, Egypt

Outcomes

Primary Outcomes

serum level of Ca15-3

Tumer marker

Time frame: 6 months

serum level of interferon gamma

Tumer marker

Time frame: 6 months

Central Contacts

amany f abd alrasol, demonstrator

CONTACT

01065211221 amanyfathy@med.sohag.edu.eg

muhammed a abd el moety, professor

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.